All News Xiangxue Pharmaceutical Co.,Ltd.

Equities

300147

CNE100000Y92

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 06/06/2024 am IST			5-day change	1st Jan Change
3.2 ^CNY	-5.04%		-9.09%	-37.86%

29/04	Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24/04	Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24/04	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Ji Qingsong agreed to acquire 18.87% stake in Hubei Tianji Pharmaceutical Co., Ltd. from Xiangxue Pharmaceutical Co.,Ltd. for CNY 200 million.	02/23/02	CI
Xiangxue Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 959.884 million in funding	02/23/02	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	21/23/21	CI
Xiangxue Pharma Trims Losses in 2022	24/23/24	MT
China's COVID scare sparks run on flu medicines, test kits as far away as Australia	15/22/15	RE
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/22/29	CI
Wuhan Yiyi Tongguan Enterprise Management Partnership (Limited Partnership) and Hubei Qingsong Yueyue Pharmaceutical Co., Ltd. agreed to acquire 35% stake in Hubei Tianji Pharmaceutical Co., Ltd. from Xiangxue Pharmaceutical Co.,Ltd. for CNY 385 million.	01/22/01	CI
Xiangxue Pharmaceutical Co.,Ltd. Approves Board Elections	28/22/28	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/22/28	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22/22/22	CI
Xiangxue Pharmaceutical Unlocks 3.4 Million Restricted Shares; Shares Rally 13%	04/22/04	MT
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/21/27	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	27/21/27	CI
Xiangxue Pharma's Shareholder Scraps Stake Sale Plan	25/21/25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Xiangxue Pharmaceutical Co.,Ltd.

Equities

300147

CNE100000Y92

All News

Filters